コネクテッドドラッグデリバリーデバイスの世界市場レポート 2025年

コネクテッドドラッグデリバリーデバイス市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年には複合年間成長率（CAGR）23.9%で219億2,000万米ドルに成長します。予測期間の成長は、慢性疾患の有病率の増加、処方された治療法の遵守に関する患者の意識の高まり、急速に進むヘルスケアITインフラ、予防医療の重視の高まり、電子カルテ（EHR）を管理するための検査室や病院でのコネクテッドデバイスの広範な採用などに起因すると考えられます。予測期間における主な動向としては、研究開発活動の活発化、技術革新の急増とデバイスの接続性の向上、機械学習と人工知能の採用急増、AR/VR技術と統合された遠隔医療プラットフォームの導入増加、ヘルスケアデバイスにおける電子技術の採用増加などが挙げられます。

コネクテッドドラッグデリバリー市場の成長は、遠隔患者モニタリング（RPM）の重要性の高まりによって促進されると予測されます。遠隔患者モニタリングは、遠隔地から患者の健康状態や医療データをモニタリングする技術を活用したヘルスケア提供手法です。コネクテッドドラッグデリバリーデバイスは、薬の使用状況や服薬アドヒアランスの正確な追跡を可能にし、タイムリーな介入を促進し、個別化されたケア管理を提供することで、RPMを強化する上で重要な役割を果たしています。例えば、米国のデジタルヘルス・ソリューション・プロバイダーであるVivalink Inc.が2023年8月に実施した調査では、患者にRPMを利用する臨床医が2021年の20%から現在では81%へと305%も大幅に増加し、これらのユーザーの84%が2024年にRPMの利用拡大を計画していることが明らかになりました。その結果、遠隔患者モニタリングの重要性の高まりが、コネクテッド・ドラッグデリバリーデバイス市場の成長を促進しています。

コネクテッドドラッグデリバリーデバイス市場の主要企業は、市場の収益性を高めるため、デジタル呼吸器健康ソリューションなどの革新的技術の開発に注力しています。コネクテッドドラッグデリバリーデバイスのデジタル呼吸器健康ソリューションは、患者の転帰を改善するために使用状況や健康データを監視しながら、呼吸器系への薬物送達を容易にする技術対応デバイスを包含します。例えば、2022年2月、米国の調剤包装・ドラッグデリバリーデバイスメーカーであるAptarGroup Inc.は、HeroTracker Senseを発表しました。この革新的なデジタルツールは、従来の定量噴霧式吸入器をスマートなコネクテッドデバイスに変え、喘息やCOPDなどの慢性呼吸器疾患の患者の服薬アドヒアランスと管理を強化します。分析・洞察用のセンサーなどの機能が組み込まれており、BreatheSmartアプリを通じて患者の服薬アドヒアランス・モニタリングをサポートし、呼吸器疾患の効果的な管理を支援します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界コネクテッドドラッグデリバリーデバイス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のコネクテッドドラッグデリバリーデバイス市場：成長率分析
• 世界のコネクテッドドラッグデリバリーデバイス市場の実績：規模と成長, 2019-2024
• 世界のコネクテッドドラッグデリバリーデバイス市場の予測：規模と成長, 2024-2029, 2034F
• 世界コネクテッドドラッグデリバリーデバイス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のコネクテッドドラッグデリバリーデバイス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• スタンドアロンコンポーネントとソフトウェア
• 統合デバイス
• 世界のコネクテッドドラッグデリバリーデバイス市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• Bluetooth
• 近距離無線通信（NFC）
• その他のテクノロジー
• 世界のコネクテッドドラッグデリバリーデバイス市場管理による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非経口
• 吸入
• 世界のコネクテッドドラッグデリバリーデバイス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 喘息
• 慢性閉塞性肺疾患
• 糖尿病管理
• その他の用途
• 世界のコネクテッドドラッグデリバリーデバイス市場、スタンドアロンコンポーネントとソフトウェアの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• モバイルアプリケーション
• 接続モジュール
• データ分析ソフトウェア
• 世界のコネクテッドドラッグデリバリーデバイス市場、統合デバイスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• スマート吸入器
• スマート自動注射器
• 接続された注射器
• ウェアラブルドラッグデリバリーデバイス

第7章 地域別・国別分析

• 世界のコネクテッドドラッグデリバリーデバイス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のコネクテッドドラッグデリバリーデバイス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• コネクテッドドラッグデリバリーデバイス市場：競合情勢
• コネクテッドドラッグデリバリーデバイス市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• Medtronic PLC
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Novo Nordisk A/S
• Merck Group
• Becton Dickinson and Company
• GlaxoSmithKline PLC
• Phillips-Medisize Corporation
• AptarGroup Inc.
• Dexcom Inc.
• West Pharmaceutical Services Inc.
• Insulet Corporation
• OPKO Health Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• コネクテッドドラッグデリバリーデバイス市場2029：新たな機会を提供する国
• コネクテッドドラッグデリバリーデバイス市場2029：新たな機会を提供するセグメント
• コネクテッドドラッグデリバリーデバイス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Connected drug delivery devices are advanced pharmaceutical tools that employ digital technology to monitor, regulate, and oversee the dispensing of medications, thereby improving adherence and patient outcomes. These devices are capable of internet connectivity, enabling data exchange between patients and healthcare providers to monitor medication usage, adjust dosages, and enhance treatment strategies.

The primary categories of connected drug delivery devices encompass standalone components, software, and integrated devices. Standalone components and software denote software or hardware capable of functioning independently or separately from a medical device that generates or utilizes it. They leverage various technologies such as Bluetooth, near-field communication (NFC), and others. These devices cater to a range of routes of administration including parenteral and inhalational methods, and find applications in conditions like asthma, chronic obstructive pulmonary disease, diabetes management, among others.

The connected drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides connected drug delivery devices market statistics, including connected drug delivery devices industry global market size, regional shares, competitors with a connected drug delivery devices market share, detailed connected drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the connected drug delivery devices industry. This connected drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The connected drug delivery devices market size has grown exponentially in recent years. It will grow from $7.48 billion in 2024 to $9.29 billion in 2025 at a compound annual growth rate (CAGR) of 24.2%. The growth in the historic period can be attributed to increased awareness of connected devices, increased importance of remote monitoring for medication adherence, increased patient engagement, widespread consumer adoption, the rapidly increasing cost of medical management.

The connected drug delivery devices market size is expected to see exponential growth in the next few years. It will grow to $21.92 billion in 2029 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, rising patient awareness about adherence to prescribed therapies, rapidly moving healthcare it infrastructure, increasing emphasis on preventive care, widespread adoption of connected devices in laboratories and hospitals for maintaining electronic health records (EHR). Major trends in the forecast period include increasing R&D activities, surge in technological innovation and the increasing connectivity of devices, soaring adoption of machine learning and artificial intelligence, rising implementation of telehealth platform integrated with AR/VR technologies, increasing adoption of electronic technology in healthcare devices.

The growth of the connected drug delivery device market is anticipated to be propelled by the increasing significance of remote patient monitoring (RPM). Remote patient monitoring is a healthcare delivery method utilizing technology to monitor patient health and medical data from a distance. Connected drug delivery devices play a crucial role in enhancing RPM by enabling precise tracking of medication usage and adherence, facilitating timely interventions, and offering personalized care management. For example, a survey conducted by Vivalink Inc., a US-based digital health solutions provider, in August 2023, revealed a significant increase of 305% in clinicians utilizing RPM on patients, rising from 20% in 2021 to 81% presently, with 84% of these users planning to expand their RPM usage in 2024. Consequently, the growing importance of remote patient monitoring is propelling the growth of the connected drug delivery device market.

Major players in the connected drug delivery devices market are concentrating on developing innovative technologies, such as digital respiratory health solutions, to enhance their market profitability. Digital respiratory health solutions for connected drug delivery devices encompass technology-enabled devices facilitating medication delivery to the respiratory system while monitoring usage and health data to improve patient outcomes. For instance, in February 2022, AptarGroup Inc., a US-based manufacturer of dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital tool transforms traditional metered-dose inhalers into smart, connected devices, enhancing medication adherence and management for individuals with chronic respiratory conditions like asthma and COPD. It incorporates features such as sensors for analytics and insights, supporting patient adherence monitoring via the BreatheSmart app, thereby aiding in the effective management of respiratory diseases.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for an undisclosed sum. This acquisition is expected to bolster Halozyme's strategy, solidify its position as a top drug delivery firm, and expand its coverage of specialized products with its best-in-class auto-injector technology and specialty commercial business. Antares Pharma Inc. is a US-based specialty pharmaceutical company operating in the connected drug delivery sector.

Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.

North America was the largest region in the connected drug delivery market in 2024. The regions covered in connected drug delivery device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the connected drug delivery device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The connected drug delivery device market consists of revenues earned by entities by providing services such as medication reminders and alerts, dose tracking, data sharing, adjustable dosing, and integration with health records. The market value includes the value of related goods sold by the service provider or included within the service offering. The connected drug delivery device market also includes sales of smart inhalers, connected insulin pumps, smart pill dispensers, wearable drug delivery devices, and digital pills that are used in providing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Connected Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on connected drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for connected drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The connected drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Standalone Components And Software; Integrated Devices
• 2) By Technology: Bluetooth; Near-Field Communication (NFC); Other Technologies
• 3) By Administration: Parenteral; Inhalational
• 4) By Application: Asthma; Chronic Obstructive Pulmonary Disease; Diabetes Management; Other Applications
• Subsegments:
• 1) By Standalone Components And Software: Mobile Applications; Connectivity Modules; Data Analytics Software
• 2) By Integrated Devices: Smart Inhalers; Smart Auto-injectors; Connected Syringes; Wearable Drug Delivery Devices
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; AstraZeneca PLC; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Connected Drug Delivery Devices Market Characteristics

3. Connected Drug Delivery Devices Market Trends And Strategies

4. Connected Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Connected Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

• 5.1. Global Connected Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Connected Drug Delivery Devices Market Growth Rate Analysis
• 5.4. Global Connected Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Connected Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Connected Drug Delivery Devices Total Addressable Market (TAM)

6. Connected Drug Delivery Devices Market Segmentation

• 6.1. Global Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standalone Components And Software
• Integrated Devices
• 6.2. Global Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bluetooth
• Near-Field Communication (NFC)
• Other Technologies
• 6.3. Global Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral
• Inhalational
• 6.4. Global Connected Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease
• Diabetes Management
• Other Applications
• 6.5. Global Connected Drug Delivery Devices Market, Sub-Segmentation Of Standalone Components And Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mobile Applications
• Connectivity Modules
• Data Analytics Software
• 6.6. Global Connected Drug Delivery Devices Market, Sub-Segmentation Of Integrated Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Smart Inhalers
• Smart Auto-injectors
• Connected Syringes
• Wearable Drug Delivery Devices

7. Connected Drug Delivery Devices Market Regional And Country Analysis

• 7.1. Global Connected Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Connected Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Connected Drug Delivery Devices Market

• 8.1. Asia-Pacific Connected Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Connected Drug Delivery Devices Market

• 9.1. China Connected Drug Delivery Devices Market Overview
• 9.2. China Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Connected Drug Delivery Devices Market

• 10.1. India Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Connected Drug Delivery Devices Market

• 11.1. Japan Connected Drug Delivery Devices Market Overview
• 11.2. Japan Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Connected Drug Delivery Devices Market

• 12.1. Australia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Connected Drug Delivery Devices Market

• 13.1. Indonesia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Connected Drug Delivery Devices Market

• 14.1. South Korea Connected Drug Delivery Devices Market Overview
• 14.2. South Korea Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Connected Drug Delivery Devices Market

• 15.1. Western Europe Connected Drug Delivery Devices Market Overview
• 15.2. Western Europe Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Connected Drug Delivery Devices Market

• 16.1. UK Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Connected Drug Delivery Devices Market

• 17.1. Germany Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Connected Drug Delivery Devices Market

• 18.1. France Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Connected Drug Delivery Devices Market

• 19.1. Italy Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Connected Drug Delivery Devices Market

• 20.1. Spain Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Connected Drug Delivery Devices Market

• 21.1. Eastern Europe Connected Drug Delivery Devices Market Overview
• 21.2. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Connected Drug Delivery Devices Market

• 22.1. Russia Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Connected Drug Delivery Devices Market

• 23.1. North America Connected Drug Delivery Devices Market Overview
• 23.2. North America Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Connected Drug Delivery Devices Market

• 24.1. USA Connected Drug Delivery Devices Market Overview
• 24.2. USA Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Connected Drug Delivery Devices Market

• 25.1. Canada Connected Drug Delivery Devices Market Overview
• 25.2. Canada Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Connected Drug Delivery Devices Market

• 26.1. South America Connected Drug Delivery Devices Market Overview
• 26.2. South America Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Connected Drug Delivery Devices Market

• 27.1. Brazil Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Connected Drug Delivery Devices Market

• 28.1. Middle East Connected Drug Delivery Devices Market Overview
• 28.2. Middle East Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Connected Drug Delivery Devices Market

• 29.1. Africa Connected Drug Delivery Devices Market Overview
• 29.2. Africa Connected Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Connected Drug Delivery Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Connected Drug Delivery Devices Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Connected Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Connected Drug Delivery Devices Market Competitive Landscape
• 30.2. Connected Drug Delivery Devices Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Connected Drug Delivery Devices Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Medtronic PLC
• 31.3. Eli Lilly and Company
• 31.4. Amgen Inc.
• 31.5. Boehringer Ingelheim International GmbH
• 31.6. Novo Nordisk A/S
• 31.7. Merck Group
• 31.8. Becton Dickinson and Company
• 31.9. GlaxoSmithKline PLC
• 31.10. Phillips-Medisize Corporation
• 31.11. AptarGroup Inc.
• 31.12. Dexcom Inc.
• 31.13. West Pharmaceutical Services Inc.
• 31.14. Insulet Corporation
• 31.15. OPKO Health Inc.

32. Global Connected Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Connected Drug Delivery Devices Market

34. Recent Developments In The Connected Drug Delivery Devices Market

35. Connected Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 35.1 Connected Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Connected Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Connected Drug Delivery Devices Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer